These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2201980)

  • 1. Chemistry of DNA alkylation and aralkylation.
    Dipple A; Moschel RC
    Prog Clin Biol Res; 1990; 340A():71-80. PubMed ID: 2201980
    [No Abstract]   [Full Text] [Related]  

  • 2. The biology of alkylating-agent cellular injury.
    Shulman LN
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):325-35. PubMed ID: 8468267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkylation of inorganic oxo compounds and insights on preventing DNA damage.
    Hamilton EE; Fanwick PE; Wilker JJ
    J Am Chem Soc; 2006 Mar; 128(10):3388-95. PubMed ID: 16522120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective alkylation of nucleic acids by carcinogens may cause miscoding in DNA. A theoretical study.
    Klopman G; Ray A
    Cancer Biochem Biophys; 1982; 6(1):31-5. PubMed ID: 7093936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA sequence selectivity of guanine-N7 alkylation by three antitumor chloroethylating agents.
    Hartley JA; Gibson NW; Kohn KW; Mattes WB
    Cancer Res; 1986 Apr; 46(4 Pt 2):1943-7. PubMed ID: 3004713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkylation of DNA and its aftermath.
    Lawley PD
    Bioessays; 1995 Jun; 17(6):561-8. PubMed ID: 7575500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for detection of DNA lesions induced by genotoxic agents; developments, and applications in monitoring human exposure.
    Baan RA; Fichtinger-Schepman AM; van Loon AA; van Delft JH
    Prog Clin Biol Res; 1991; 372():229-41. PubMed ID: 1956921
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of cyclic nucleic acid base adducts in carcinogenesis and mutagenesis.
    Bartsch H
    IARC Sci Publ; 1986; (70):3-14. PubMed ID: 3793179
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of the chemical structure on the biological tendency of cytostatic compounds related to dibromomanitol. II. Mechanism of action.
    Horváth IP; Institóris L
    Arzneimittelforschung; 1967 Feb; 17(2):149-55. PubMed ID: 5631482
    [No Abstract]   [Full Text] [Related]  

  • 10. Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines.
    Cloutier JF; Castonguay A; O'Connor TR; Drouin R
    J Mol Biol; 2001 Feb; 306(2):169-88. PubMed ID: 11237592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reactive oligonucleotide derivatives containing methylphosphonate groups. V. Increased effectiveness of complementary addressed modification of target DNA by alkylating derivatives of methylphosphonate analogs of octathymidylate containing N-(2-hydroxyethyl)phenazinium residues].
    Amirkhanov NV; Zarytova VF
    Bioorg Khim; 1990 Mar; 16(3):370-8. PubMed ID: 2357240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA alkylation studies of combined treatment with methylnitrosourea and ethylmethanesulfonate in mice.
    Platzek T; Bochert G
    Teratog Carcinog Mutagen; 2000; 20(1):27-34. PubMed ID: 10607375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of 6-benzyl-1,3-benzodioxole derivatives on the alkylation of tubulin.
    Roach MC; Trcka PP; Jurd L; Luduena RF
    Mol Pharmacol; 1987 Sep; 32(3):432-6. PubMed ID: 3670279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 3,4-epoxypiperidine structure as a novel and simple DNA-cleavage unit.
    Miyashita K; Park M; Adachi S; Seki S; Obika S; Imanishi T
    Bioorg Med Chem Lett; 2002 Apr; 12(7):1075-7. PubMed ID: 11909721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible repair of cytogenetic damage to human lymphocytes: adaptation to low-level exposures to DNA-damaging agents.
    Wolff S; Afzal V; Olivieri G
    Prog Clin Biol Res; 1990; 340B():397-405. PubMed ID: 2203018
    [No Abstract]   [Full Text] [Related]  

  • 16. Do dose response thresholds exist for genotoxic alkylating agents?
    Jenkins GJ; Doak SH; Johnson GE; Quick E; Waters EM; Parry JM
    Mutagenesis; 2005 Nov; 20(6):389-98. PubMed ID: 16135536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of DNA alkylation by 1-(2-chloroethyl)-3-alkyl-3-acyltriazenes depends on the structure of the acyl group: kinetic and product studies.
    Smith MB; Schmidt BF; Czerwinski G; Taneyhill LA; Snyder EJ; Kline AM; Michejda CJ; Smith RH
    Chem Res Toxicol; 1996 Mar; 9(2):466-75. PubMed ID: 8839051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of alkylation products of styrene oxide in single- and double-stranded DNA.
    Vodicka P; Hemminki K
    Carcinogenesis; 1988 Sep; 9(9):1657-60. PubMed ID: 3409468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumour alkylating agents: cytotoxic action and organ toxicity.
    Connors TA
    IARC Sci Publ; 1986; (78):143-5. PubMed ID: 3583387
    [No Abstract]   [Full Text] [Related]  

  • 20. [Repair of DNA-protein cross-links induced by antineoplastic alkylating agents].
    Lomova TIu; Shakhova IK; Shkodinskaia EN
    Biull Eksp Biol Med; 1981 Jul; 92(7):74-6. PubMed ID: 7295949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.